Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Visceral leishmaniasis in heavily pretreated multiple myeloma patients a case series of 17 patients from the Mediterranean Coast of Spain

Monreal Bernal A, Berenguer Piqueras M, Ortiz Salvador P, et al. Informa UK Limited. Annals of Medicine. 2025; 57 (1) : 10.
Download PDF
Publication

Spatial variation in time to diagnosis of visceral leishmaniasis in Bihar, India

Nightingale ES, Bindroo J, Dubey P, et al. Springer Science and Business Media LLC. BMC Global and Public Health. 2025; 3 (1) : 13.
Download PDF
Publication

Cutaneous leishmaniasis in Algeria: An expanding endemic disease

Bentahar A, Moualek I, Messahel NE, et al. Elsevier BV. Comparative Immunology, Microbiology and Infectious Diseases. 2025;
Download PDF
Publication

Tackling schistosomiasis in fisherfolk communities in Uganda: Enablers and challenges for implementing paediatric schistosomiasis mass drug administration from the perspective of district health authorities

Reigl LS, Lange IL, Okan O, et al. Springer Science and Business Media LLC. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2025;
Download PDF
Publication

Albendazole–ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2/3 trial

Krolewiecki A, Kepha S, Fleitas PE, et al. Elsevier BV. The Lancet Infectious Diseases. 2025; 25 (5) : 548-559.
Download PDF
Publication

Development and validation of a questionnaire assessing knowledge, attitude, and practice of snake envenomation among health care providers (KAPSE-HCPQ) in sub‐Saharan African countries

Taha SHN, Badr El Dine F, Abdel‐Rahman S, et al. Wiley. Tropical Medicine & International Health. 2025;
Download PDF
Publication

Longitudinal monitoring of cell adhesion molecules in acute Chagas disease patients and prognosis after treatment with benznidazole

Vaitkevicius‐Antão V, Silva BA, da Silva Barros M, et al. Wiley. Tropical Medicine & International Health. 2025;
Download PDF
Publication

Cutaneous reactions during treatment with Nifurtimox or Benznidazole among Trypanosoma cruzi seropositive adults without symptomatic cardiomyopathy: A safety sub analysis of a placebo‐controlled randomised trial

Villar JC, Saavedra MF, Bermúdez PA, et al. Wiley. Tropical Medicine & International Health. 2025;
Download PDF
Publication

Population-level impact of mass drug administration against schistosomiasis with anthelmintic drugs targeting juvenile schistosomes: a modelling study

Singer BJ, Gomes M, Coulibaly JT, et al. Elsevier BV. The Lancet Microbe. 2025;
Download PDF
Publication

A Cross-Sectional Study Examining the Role of Climate Variability in Shaping Trypanosomiasis Trends in Binga District, Zimbabwe (2008-2023): A Multi-Method Survey

Ndiweni N, Livias Moyo P, Njabulo Nunu W, et al. SAGE Publishing. Sage Journals. 2025;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 9
  • Next page ››
Subscribe to Neglected tropical diseases (NTDs)

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD